Work

Cooperation of MT1-MMP and receptor tyrosine kinase signalling in cancer cell invasion

Year: 2013
Type: dissertation
Abstract: Cancer metastasis is a stepwise process of cancer cell dissemination from a primary tumour into adjacent and distant tissues and causes around 90 % of cancer-associated mortality. Metastatic cancer dissemination is initiated and promoted by intracellular and intercellular signalling within tumour microenvironment. Extracellular matrix (ECM) degradation also promotes cancer cell invasion and metastasis in many types of cancer. Membrane type-1 matrix metalloproteinase (MT1-MMP) degrades variety of ECM components and cell surface proteins as well as modulates numerous intracellular signalling pathways to regulate cancer invasion. The molecular mechanisms of pro-invasive MT1-MMP activities are getting more attention to reveal cancer-associated cooperative signalling, which will aid in planning more efficient and effective therapeutic interventions for patients with cancer. In the current studies, we performed a genome-wide gain-of-function human kinome screen to identify cancer-associated upstream and co-operating signalling for MT1-MMP activities. We identified both known and novel positive regulators of MT1-MMP. Among the novel MT1-MMP regulators we focused on the functions of two receptor tyrosine kinases, namely fibroblast growth factor receptor 4 (FGFR4) and Eph receptor type A2 (EphA2) in cancer cell invasion. Overexpression and aberrant signalling of these kinases are linked to aggressive cancer progression and anti-cancer drug resistance. A single nucleotide polymorphism (SNP) of FGFR4 (G388R) associated with poor cancer prognosis was identified as a positive regulator of MT1-MMP activity. We revealed that the complexes of MT1-MMP and FGFR4-R388 risk variant stabilised and activated both MT1-MMP and FGFR4 proteins, resulting in enhancing FGF signalling and pericellular proteolytic activities of MT1-MMP. The FGFR4-R388-MT1-MMP axis induced epithelial-to-mesenchymal transition, promoting prostate carcinoma cell invasion and invasive growth within collagen matrix and in mouse xenograft models. In contrast, the FGFR4-G388 variant and MT1-MMP down-regulated each other. EphA2 was co-expressed with MT1-MMP in invasive breast carcinoma cells, where EphA2 signalling increased MT1-MMP transcription. MT1-MMP in turn cleaved EphA2 in protein complexes on the same cell-surface. This cleavage coupled with EphA2-dependent Src activation triggered intracellular EphA2 translocation and an increase in RhoA activity, leading to actomyosine contraction, cell-cell repulsion, and cell junction disassembly. These signalling events ultimately induced cell invasion phenotype transition from collective to single-cell within three-dimensional collagen matrix and in vivo. Taken together, these studies identified the FGFR4-R388 variant and EphA2 as novel co-operators for pro-invasive MT1-MMP activities in cancer invasion. FGFR4 genetic background affects the activity of an FGFR4-MT1-MMP complex in cancer progression, and an EphA2-MT1-MMP axis regulates cancer invasion plasticity. These findings provide novel insights into the cooperative molecular basis of pro-invasive capabilities of MT1-MMP and FGF and EphA2 signalling in cancer cell invasion.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W2626568327
Cites: 372
Cited by:
Related to: 10